Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...

Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.

Alex Sticchi interviews Julien Dreyfus about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam, which suggests that, in patients with severe TR, a curative intervention should be considered at an early stage of the disease as assessed by...

Aaysha Cader interviews Barbara Elisabeth Stahli on the study design and results that she presented during the ESC Congress 2023 in Amsterdam. 

Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease.

Ali Nazmi Calik interviews Duk-Woo Park & Do-Yoon Kang regarding the results of the OCTIVUS trial which were presented during the ESC Congress 2023 in Amsterdam.

Key message is that optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI).

Ali Nazmi Calik interviews Gregg Stone about the results of the meta-analysis which he presented during the ESC Congress 2023 in Amsterdam. It showed that intravascular imaging-guided PCI (IVUS or OCT) reduces target lesion failure, cardiac death, myocardial infarction, and revascularization compared to angiography-guided PCI.

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Nicola Ryan provides her take on the final results of OPT-BIRISK which were presented by Yaling Han during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation alone as the trial has not yet been published.

Join Peter Lüdike and Maurizio Taramasso as they discuss the key device-related issues for an optimal TEER procedure and how the latest generation of Pascal Precision system fits these needs.

This interview was filmed at PCR London Valves 2023: see more videos here.

In this roundtable discussion, Patrick Serruys, Andreas Baumbach, and Christian Juhl Terkelsen explore the innovative concept of intermediate sizes and extra-large valves. They introduce a new valve which is another step forward in addressing the unmet needs of the interventional cardiovascular community.

This interview was filmed at...

In this expert interview, Vinayak Bapat interviews Anita Asgar regarding the challenges physicians are facing today with valve-in-valve patients and the potential use of DurAVR, a new balloon-expandable device, in valve-in-valve procedures.

This interview was filmed at PCR London Valves 2023: see more videos here.

Join this discussion between Christopher Meduri, Susheel Kodali and João Cavalcante covering the early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve called DurAVR™.

This video was recorded for EuroPCR 2023. View more videos and interviews here

The annual World-Leading Course in interventional cardiovascular medicine is the official meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI).  Thousands of participants will once again be gathering to share their knowledge, skills and experience on 20-23 May 2025, at the Palais des Congrès in...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Follow this conversation between Rony Mathew, Rishi Sethi and Ashok Seth at EuroPCR 2023 and learn more about advances in the management of bifurcation lesions.

At a time when the number of patients suffering from bifurcation lesions is constantly rising and represents a major challenge, take a closer...

Shrilla Banerjee and Valeria Paradies were invited to talk about a subject that was very often raised during EuroPCR 2023: how to save both the patient and the myocardium in case of cardiogenic shock?

As there is currently little evidence of the benefits of mechanical circulatory assistance, which...